PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-4.87%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$7.52B
AUM Growth
+$7.52B
(-19%)
Cap. Flow
-$663M
Cap. Flow
% of AUM
-8.82%
Top 10 Holdings %
Top 10 Hldgs %
42.45%
Holding
173
New
32
Increased
18
Reduced
39
Closed
33
Top Buys
| 1 |
LABP
Landos Biopharma, Inc. Common Stock
LABP
|
$141M |
| 2 |
BridgeBio Pharma
BBIO
|
$64.7M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$55.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$49.5M |
| 5 |
Exact Sciences
EXAS
|
$46.6M |
Top Sells
| 1 |
Novavax
NVAX
|
$116M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$95.2M |
| 3 |
Neurocrine Biosciences
NBIX
|
$93.1M |
| 4 |
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
|
$90.4M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$73.5M |
Sector Composition
| 1 | Healthcare | 84.38% |
| 2 | Financials | 0.28% |
| 3 | Industrials | 0.21% |
| 4 | Consumer Discretionary | 0.02% |
| 5 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGRX
51
DELISTED
Agile Therapeutics, Inc
AGRX
| $33.1M | 0.42% |
15,919,925
| – | – |
|
|
PRVB
52
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $29.9M | 0.38% |
2,852,058
-1,372,331
| -32% | -$14.4M |
|
|
CMPS
53
Compass Pathways
CMPS
$452M
| $29.4M | 0.37% |
797,404
-250,000
| -24% | -$9.2M |
|
54
United Therapeutics
UTHR
$17.7B
| $29.3M | 0.37% |
+175,000
| New | +$29.3M |
|
55
ADMA Biologics
ADMA
$4.03B
| $29.2M | 0.37% |
16,584,802
| – | – |
|
56
Nuvation Bio
NUVB
$1.08B
| $29M | 0.37% |
+3,041,004
| New | +$29M |
|
|
ISEE
57
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $28.3M | 0.36% |
4,585,512
+102,799
| +2% | +$635K |
|
58
Immatics
IMTX
$662M
| $28M | 0.35% |
2,500,000
| – | – |
|
59
Cogent Biosciences
COGT
$1.83B
| $28M | 0.35% |
3,188,750
| – | – |
|
|
ONCR
60
DELISTED
Oncorus, Inc.
ONCR
| $27.7M | 0.35% |
1,989,987
| – | – |
|
61
Arrowhead Research
ARWR
$3.84B
| $27.1M | 0.34% |
409,341
-661,473
| -62% | -$43.9M |
|
62
Stoke Therapeutics
STOK
$1.08B
| $26.1M | 0.33% |
671,978
| – | – |
|
63
Alphatec Holdings
ATEC
$2.35B
| $25.5M | 0.32% |
+1,800,180
| New | +$25.5M |
|
64
PMV Pharmaceuticals
PMVP
$82.1M
| $24.6M | 0.31% |
746,557
-138,999
| -16% | -$4.57M |
|
|
VRNA
65
Verona Pharma
VRNA
$9.18B
| $24.2M | 0.31% |
2,888,889
| – | – |
|
66
Avidity Biosciences
RNA
$6.12B
| $24M | 0.3% |
1,099,028
-136,790
| -11% | -$2.98M |
|
67
Health Catalyst
HCAT
$228M
| $23.7M | 0.3% |
506,084
+230,000
| +83% | +$10.8M |
|
68
Forte Biosciences
FBRX
$138M
| $23.5M | 0.3% |
685,000
+335,000
| +96% | +$11.5M |
|
69
Collegium Pharmaceutical
COLL
$1.25B
| $23.2M | 0.29% |
978,277
-1,079,791
| -52% | -$25.6M |
|
|
FUSN
70
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $20.9M | 0.26% |
1,950,167
-285,816
| -13% | -$3.06M |
|
|
DRNA
71
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $20.5M | 0.26% |
800,000
| – | – |
|
|
ONEM
72
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $20.3M | 0.26% |
519,844
| – | – |
|
|
MREO
73
Mereo BioPharma
MREO
$275M
| $20.2M | 0.26% |
+6,000,000
| New | +$20.2M |
|
74
Korro Bio
KRRO
$245M
| $20.1M | 0.25% |
2,113,661
-1,145,974
| -35% | -$10.9M |
|
75
4D Molecular Therapeutics
FDMT
$302M
| $19.3M | 0.24% |
444,878
-155,378
| -26% | -$6.74M |
|